dr. joanne blum on the function of talazoparib in locally advanced and/or metastatic breast cancer
Published 8 years ago • 329 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
1:58
dr. joanne blum on the embraca trial in metastatic brca-mutant breast cancer
-
2:47
talave: induction talazoparib with parp inhibition in breast cancer
-
3:27
tripathy discusses a study of talazoparib in brca-mutated advanced breast cancer
-
0:55
dr. blum on takeaways from abc trials for breast cancer
-
1:01:40
breast cancer adjuvant systemic therapy prof. sarin's teaching rounds
-
1:01:33
watch: menopause, breast cancer, and the journey forward | dr. avrum bluming & dr. corinne menn
-
51:23
can you have hormone balance with breast cancer? with esther blum
-
4:34
lasofoxifene vs fulvestrant for locally advanced/metastatic er /her2- breast cancer: elaine trial
-
26:42
the issue with elle macpherson’s holistic treatment for breast cancer | extra minutes
-
1:02
phase iii trial of pf-07220060 and fulvestrant in hr /her2- breast cancer
-
1:02
how useful are checkpoint inhibitors in the treatment of breast cancer?
-
1:16
parp inhibitors improve outcomes, qol in breast cancer
-
34:21
expanding options for her2 advanced breast cancer: taking trial data to the clinic
-
3:35
the benefits of adjuvant cdk4/6 and parp inhibition in breast cancer
-
59:38
the latest in breast cancer treatment and prevention with anne m. wallace - research on aging
-
1:39
treatment for her2 metastatic breast cancer
-
1:03
azd2014 for treating er metastatic breast cancer – mode of action and trial results
-
1:10
dr. andrew d. seidman on targeted treatments in breast cancer
-
1:01
the metastatic breast cancer project
-
2:15
the evolution of advanced breast cancer management
-
4:51
telazoparib vs physicians choice for patients with mbrca1 breast cancer
-
3:22
begonia: datopotamab deruxtecan and durvalumab in metastatic triple-negative breast cancer